Back
Apellis Pharmaceuticals Vs. Cassava Sciences Industry Stock Comparison
Buy
51
APLS
Apellis Pharmaceuticals
Last Price:
32.62
Seasonality Move:
15.03%
Sell
20
SAVA
Cassava Sciences
Last Price:
3.83
Seasonality Move:
36.76%
Buy
51
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $31.91. The Score for APLS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Cassava Sciences (SAVA)
is a Sell
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $4.30. The Score for SAVA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- SAVA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $31.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $4.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing slight buying pressure.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 62.71 | Buy |
| Chaikin Money Flow: | -1029134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.89 - 29.53) | Buy |
| Bollinger Bands (100): | (28.51 - 38.57) | Sell |
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.61 | Sell |
| Relative Strength Index (14 RSI): | 23.57 | Sell |
| Chaikin Money Flow: | 3252101 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.23 - 30.51) | Sell |
| Bollinger Bands (100): | (17.97 - 31.33) | Sell |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.43 | Buy |
| 20-day SMA: | 28.45 | Buy |
| 50-day SMA: | 28.99 | Buy |
| 200-day SMA: | 42.18 | Sell |
| 8-day EMA: | 29.25 | Buy |
| 20-day EMA: | 28.68 | Buy |
| 50-day EMA: | 29.96 | Buy |
| 200-day EMA: | 39.38 | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.75 | Sell |
| 20-day SMA: | 25.49 | Sell |
| 50-day SMA: | 27.05 | Sell |
| 200-day SMA: | 22.83 | Sell |
| 8-day EMA: | 22.44 | Sell |
| 20-day EMA: | 24.97 | Sell |
| 50-day EMA: | 25.95 | Sell |
| 200-day EMA: | 24.04 | Sell |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.77 per share, and an increase next year of $0.81 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.59 per share.
Apellis Pharmaceuticals Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cassava Sciences Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||